NL-OMON36357已完成不适用
Gadobutrol (Gadovist®) versus gadofosveset-trisodium (Vasovist®) in MR venography of the peripheral venous vasculature in deep vein thrombosis: is their a need for blood pool contrast agents? - MR Venography in deep vein thrombosis
Medisch Universitair Ziekenhuis Maastricht0 个研究点目标入组 20 人开始时间: 待定最近更新:
适应症
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 发起方
- 入组人数
- 20
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- 18 至 99（—）
入选标准
- •* Age between 18-65 years
- •* Objectively documented DVT
- •* Patient scheduled for CE-MRV
- •* Patient able to undergo CE-MRV twice within one week
- •* Patient is not scheduled to receive invasive treatment between both examinations
排除标准
- •* Hemodynamic instability
- •* Known allergy for gadolinium based MR contrast agents
- •* Contra-indications for MRI
- •* eGFR < 30 ml/min
- •* Claustrophobia
- •* Pregnancy
研究者
相似试验
进行中（未招募）
不适用
Comparison of two Gadolinium containing MR contrast media in patients with symptoms of cerebrovascular diseasePatients with high grade carotid artery stenosis or acute cerebral ischemiaEUCTR2012-001582-33-DEniversity Hospital Erlangen
已完成
4 期
Intraindividual cross-over comparison of Gadobutroland Gadoterate enhanced combined DSC-MR-Perfusion and MRAngiographyin patients with cerebrovascular diseaseSubjects with acute stroke and/or subjects harboring an intracranial stenosis or extracranial ICA stenosisI67Other cerebrovascular diseasesDRKS00009914niversitätsklinikum Erlangen73
进行中（未招募）
不适用
Gadofosveset Trisodium (Vasovist®) zur kontrastverstärkten MR-Angiographie der supraaortalen Arterien und zur Darstellung der Gefäßwand in der primären Kontrastmittelpassage („first pass) und in der intravasalen Phase („steady state) bei 3.OTEUCTR2007-003263-52-DEniversity of Bonn50
已完成
2 期
Comparison of Gadobutrol and Gadobenate Dimeglumin for Delayed Enhancement Cardiac MRISubacute/Chronic Myocardial InfarctionNCT01655290Technical University of Munich20
Unknown
不适用
Gadofosveset Trisodium (Ablavar, Gdfos) in Distinguishing Hemangiomas and Metastases: A Prospective TrialMetastasesLiver NeoplasmsCancerNCT02036008Sunnybrook Health Sciences Centre150